Select Transaction Experience: - Sale of Fluid Components International (FCI) to Process Sensing Technologies (PST), a portfolio company of AEA Investors- Sale of Imagine Reporting to Lexitas, a portfolio company of Apax Partners- Sale of La Jolla Logic to Boecore, a portfolio company of Enlightenment Capital- Sale of Supreme Optimization to Trinity Hunt Partners- Sale of undisclosed Engineering Services firm to Fortune 50 Technology Company- Sale of Kirei to Carnegie Fabrics, a portfolio company of Calera Capital

At Objective, Investment Banking & Valuation (“Objective”) our firm’s name embodies our core mission: Your Objective Is Ours. Objective Investment Banking & Valuation is a leading investment banking and valuation firm offering Sell-Side M&A and Valuation Advisory Services for middle market companies. Founded in 2006, Objective’s seasoned professionals have collectively executed over 500 M&A advisory engagements and thousands of business valuations. Objective operates as two distinct practices: Investment Banking and Valuation. Our Investment Banking practice specializes in sell-side advisory services for middle market companies across our core industry practice groups, bringing in-depth knowledge and understanding of each industry’s trends, challenges, and opportunities. We are known for our expertise in navigating complex transactions while offering personalized attention to every client. -Investment Banking industry groups: +Business Services +Consumer +Healthcare & Life Sciences +Manufacturing & Distribution +Technology For more information, please visit http://www.objectivecp.com. Registered Representative of and Securities Products offered through BA Securities, LLC Member FINRA (www.FINRA.org) SIPC (www.SIPC.org). Objective Capital Partners, LLC and BA Securities, LLC are separate and independent entities. Any testimonial or endorsement may not be representative of the experience of other customers and is no guarantee of future performance or success.

• Analyst with capital raise and sell-side advisory team; worked on projects to assist growth companies prepare for andexecute capital raises.• Built detailed bottom up 3-statement financial models to evaluate performance under various operating scenarios.• Assisted in preparation of company valuations using various methodologies including discounted cash flow, leveragedbuyout, trading comparables, and transaction comparables.• Prepared materials for use in client meetings; covering topics such as strategic alternatives, capital markets activity andgeneral corporate finance.• Supported Managing Director on numerous active deal processes including initiating investor outreach, developmentof investor presentation materials, and review of diligence materials and tracking documents.• Research, analyze, present, and document drafting elements of a developing transaction.• Played an active role in sourcing and facilitating investments from VC firms, private equity firms, and family offices.• Conducted in-depth industry and market research to identify competitive landscapes.

• Assisted in the development and composition of investor ready documentation including tailored pitch decks, financialmodels, and other transaction materials.• Performed market research on client specific industries and sectors• Helped organize data room requests

• Led team of four in analyzing $5.7B medical device manufacturer and gave a buy, sell, or hold rating.• Conducted valuation using public comparables and DCF methods for in-depth analysis which showed the company was over-valued by approximately 30%.• Won 2nd place in region by preparing 20+ page equity research report on Tandem Diabetes Care and presented a detailed pitch deck describing investment thesis to a judging panel consisting of industry professionals.